A comprehensive clinical review of Next-Generation Sequencing (NGS) for preimplantation genetic testing for aneuploidies (PGT-A), evaluating HFEA evidence ratings, embryo biopsy safety, and chromosomal mosaicism.
Preimplantation Genetic Testing for Aneuploidies (PGT-A) utilizing high-throughput Next-Generation Sequencing (NGS) allows embryologists to evaluate all 24 human chromosomes for numerical abnormalities before embryo transfer. Meva Clinic coordinates comprehensive fertility diagnostic pathways with accredited partner embryology laboratories in Northern Cyprus. Explore our pathway on IVF Cyprus Special.
Clinical Assessment
Would you like a confidential medical review?
Share your treatment question with our international patient team. Suitability and treatment decisions are confirmed by the responsible licensed physician after clinical assessment.
Please do not send sensitive medical documents in your first message. Our team will explain the secure next step.
How NGS Works: Blastocyst Biopsy and Chromosomal Analysis
When embryos develop to Day 5 or 6 blastocysts, experienced embryologists perform a trophectoderm biopsy, carefully extracting 5 to 8 cells destined to form placental tissue while leaving the inner cell mass (fetal precursor) intact. The biopsied cellular DNA is amplified and analyzed via NGS to identify whole or partial chromosomal gains (trisomies) or losses (monosomies).
Clinical Indications and HFEA Evidence Rating Context
The UK Human Fertilisation and Embryology Authority (HFEA) provides a nuanced traffic-light assessment for PGT-A: HFEA rates PGT-A 'green' for reducing miscarriage risk per transfer for specific patient groups (such as women of advanced maternal age or couples with a history of recurrent pregnancy loss), because avoiding the transfer of aneuploid embryos reduces early pregnancy failure. However, HFEA rates PGT-A 'red' for increasing the cumulative chance of having a baby across all unselected fertility patients, as screening does not fix genetically abnormal embryos or generate more viable oocytes. PGT-A does not guarantee pregnancy or eliminate miscarriage entirely, as uterine receptivity and anatomical factors also govern implantation.
Biological Realities: Mosaicism and Diagnostic Limits
Patients must be counseled on biological phenomena such as embryo mosaicism (where biopsied cells contain a mix of normal and abnormal chromosomes). Expert genetic counseling helps couples interpret complex biopsy reports to establish informed transfer strategies.
Frequently Asked Questions
Does PGT-A genetic screening guarantee a live birth?↓
No. PGT-A screens for numerical chromosomal balance (euploidy) to reduce aneuploidy-related transfer failures, but successful implantation also depends on endometrial health, hormonal balance, and anatomical factors.
Does embryo biopsy harm the developing blastocyst?↓
In accredited embryology laboratories with experienced embryologists, trophectoderm biopsy at the blastocyst stage has a very low risk of compromising embryo viability.
Clinical Assessment
Would you like a confidential medical review?
Share your treatment question with our international patient team. Suitability and treatment decisions are confirmed by the responsible licensed physician after clinical assessment.
Please do not send sensitive medical documents in your first message. Our team will explain the secure next step.
This content is maintained by Meva Clinic’s Clinical Care Team for patient guidance and clinical transparency. Final treatment suitability, operating physician assignment, surgical planning, and medical decisions are confirmed only after medical history review, in-person consultation, diagnostic tests, anesthesia evaluation, and doctor availability.
Meva Clinic Clinical Care
Partner Hospital Quality & Medical Network Standards
JCI Partner Hospitals
ISO / TÜV Quality Standards
Licensed Providers in Türkiye
ISAPS-Affiliated Partner Surgeons
International Quality Management
Accreditation and society references relate to selected partner hospitals, provider institutions, or individual partner surgeons where applicable. Meva Clinic coordinates international patient care through licensed healthcare providers and specialist medical partners.
